New Evidence on the Value Additivity Principle

AbstractThe DCF method or multiples are used to value companies in practice. Starting with the value additivity principle, the paper presents a general framework for DCF valuation. This framework allows defining stepwise and aggregated approaches to value risky cash flows and identifying inconsistent approaches. The framework helps to integrate sales, contribution margin, operating leverage, and financial leverage into valuation approaches and shows the assumptions implied when multiples are used.

Download Full-text

The Market Valuation of Bank Shares: With Implications for the Value Additivity Principle

Financial Markets Institutions and Instruments ◽

10.1111/1468-0416.00013 ◽

1997 ◽

Vol 6 (5) ◽

pp. 1-22 ◽

Cited By ~ 2

Author(s):

James S. Ang ◽

Jeffrey A. Clark

Keyword(s):

Market Valuation ◽

Additivity Principle ◽

Value Additivity

Download Full-text

Systematic effects in observed parallaxes

International Astronomical Union Colloquium ◽

10.1017/s0252921100073887 ◽

1978 ◽

Vol 48 ◽

pp. 31-35

Author(s):

R. B. Hanson

Keyword(s):

Error Estimates ◽

Zero Point ◽

Absolute Zero ◽

Apparent Magnitude ◽

Coherent System ◽

Preliminary Results ◽

General Catalogue ◽

Systematic Effects ◽

New Evidence ◽

Right Ascension

Several outstanding problems affecting the existing parallaxes should be resolved to form a coherent system for the new General Catalogue proposed by van Altena, as well as to improve luminosity calibrations and other parallax applications. Lutz has reviewed several of these problems, such as: (A) systematic differences between observatories, (B) external error estimates, (C) the absolute zero point, and (D) systematic observational effects (in right ascension, declination, apparent magnitude, etc.). Here we explore the use of cluster and spectroscopic parallaxes, and the distributions of observed parallaxes, to bring new evidence to bear on these classic problems. Several preliminary results have been obtained.

Download Full-text

MERLIN Finds New Evidence of Ranolazine Safety

Internal Medicine News ◽

10.1016/s1097-8690(07)70525-5 ◽

2007 ◽

Vol 40 (9) ◽

pp. 36

Author(s):

BRUCE JANCIN

Keyword(s):

New Evidence

Download Full-text

Vaccination for travellers – new evidence and recommendations

Therapeutische Umschau ◽

10.1024/0040-5930.58.6.362 ◽

2001 ◽

Vol 58 (6) ◽

pp. 362-366 ◽

Cited By ~ 2

Author(s):

Matius P. Stürchler ◽

R. P. Steffen

Keyword(s):

Hepatitis B ◽

Hepatitis A ◽

New Evidence

Impfungen sind einfache und effektive Maßnahmen zur Verhinderung von Reisekrankheiten. Compliance-Probleme sind gering, da alle Impfungen noch vor Abreise verabreicht werden und bei manchen Impfungen nur eine Dosis für den zuverlässigen Schutz nötig ist. Für jeden Reisenden sind die Hepatitis A- und die Diphtherie-Tetanus-Impfung empfohlen, für Asien und Afrika auch die Polioimpfung. Bei Reisen >30 Tagen, jüngeren Personen und Reisenden mit Risikoverhalten sollte immer auch eine Hepatitis B-Impfung, eventuell als Kombination mit Hepatitis A in Betracht gezogen werden. Je nach Reisestil, -destination und -dauer können auch weitere Impfungen wie z.B. die Typhus-, Tollwut-, Zeckenenzephalitis-, Grippe-, Masern-Mumps-Röteln-, Gelbfieber-, Meningokokkenmeningitis- und die Japanische Enzephalitis-Impfung in Frage kommen. Mehrere Impfungen können gleichzeitig verabreicht werden – eine Staffelung ist nicht nötig. i BAG Supplementum VI, Stand Juli 2000 «Impfungen für Auslandreisende»; http://www.admin.ch/bag/infekt/prev/reisemed/index.htm; Safetravel http://www.safetravel.ch; Tropimed

Download Full-text